Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 Patients: Results from the NOR-Solidarity Randomised Trial

Autor: Tuva B. Dahl, Hilde Skudal, Ane-Kristine Finbråten, Skåra Kh, Le Lak, Kristian Tonby, Cathrine Fladeby, Bård Reiakvam Kittang, Raisa Hannula, Andreas Barratt-Due, Fridtjof Lund-Johansen, Alexander Mathiessen, Anne Margarita Dyrhol-Riise, Bjørn Blomberg, Asgeir Johannessen, Carl Magnus Ystrøm, Lars Thoresen, Katerina Nezvalova Henriksen, Hedda Hoel, Mette Haugli, Pawel Mielnik, Saad Aballi, Hoff Dal, Gernot Ernst, Birgitte Tholin, Åse Berg, Marius Trøseid, Ragnhild Eiken, Susanne Gjeruldsen Dudman, Jan Terje Andersen, Olav Dalgard, Trine Kåsine, Lars Heggelund, Steffensen A, Müller F, Anders Benjamin Kildal, Skei Nv, Roy Bjørkholt Olsen, P. Aukrust, Inge C. Olsen, Tran T, Aleksander Rygh Holten, Anders Aune Tveita

Publikováno v: SSRN Electronic Journal.

Background: There is an urgent need for new treatment modalities in COVID-19 patients. Recently, the WHO Solidarity trial showed no effects of remdesivir or hydroxychloroquine (HCQ) on mortality. However, the antiviral effects of these drugs and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::494720c36df68241feda04a9e18f0df5
https://doi.org/10.2139/ssrn.3774182

Telomere length in relation to fecundability and use of assisted reproductive technologies: the Norwegian Mother, Father, and Child Cohort Study.

Autor: Skåra KH; Norwegian Institute of Public Health., Lee Y; Norwegian Institute of Public Health., Jugessur A; Norwegian Institute of Public Health., Gjessing HK; Norwegian Institute of Public Health., Aviv A; The State University of New Jersey., Brumpton B; K.G. Jebsen Centre for Genetic Epidemiology, NTNU - Norwegian University of Science and Technology., Naess Ø; University of Oslo., Hernáez Á; Norwegian Institute of Public Health., Hanevik HI; Norwegian Institute of Public Health., Magnus P; Norwegian Institute of Public Health., Magnus MC; Norwegian Institute of Public Health.

Publikováno v: Research square [Res Sq] 2024 Jun 03. Date of Electronic Publication: 2024 Jun 03.

Placental efflux transporters and antiseizure or antidepressant medication use impact birth weight in MoBa cohort.

Autor: Hernandez MH; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.; Blanquerna School of Health Sciences, University Ramon Llull, Barcelona, Spain., Cohen JM; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway., Skåra KH; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.; Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway., Grindstad TK; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Lee Y; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Njølstad PR; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.; Children and Youth Clinic, Haukeland University Hospital, Bergen, Norway., Andreassen OA; Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Corfield EC; Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway.; Nic Waals Institute, Lovisenberg Diakonale Hospital, Oslo, Norway., Havdahl A; Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway.; Nic Waals Institute, Lovisenberg Diakonale Hospital, Oslo, Norway.; PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK., Molden E; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.; Section for Pharmacology and Pharmaceutical Department of Pharmacy, University of Oslo, Oslo, Norway., Furu K; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway., Magnus MC; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Hernaez A; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.; Blanquerna School of Health Sciences, University Ramon Llull, Barcelona, Spain.

Publikováno v: IScience [iScience] 2024 Feb 20; Vol. 27 (3), pp. 109285. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).

Parental genetically predicted liability for coronary heart disease and risk of adverse pregnancy outcomes: a cohort study.

Autor: Hernáez Á; Centre for Fertility and Health, Norwegian Institute of Public Health, Skøyen, 0213, PO 222, Oslo, Norway. alvaro.hernaez@fhi.no.; Blanquerna School of Health Sciences, Universitat Ramon Llull, Barcelona, Spain. alvaro.hernaez@fhi.no.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain. alvaro.hernaez@fhi.no., Skåra KH; Centre for Fertility and Health, Norwegian Institute of Public Health, Skøyen, 0213, PO 222, Oslo, Norway.; Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway., Page CM; Centre for Fertility and Health, Norwegian Institute of Public Health, Skøyen, 0213, PO 222, Oslo, Norway.; Department of Physical Health and Ageing, Division for Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway., Mitter VR; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Hernández MH; Centre for Fertility and Health, Norwegian Institute of Public Health, Skøyen, 0213, PO 222, Oslo, Norway.; Blanquerna School of Health Sciences, Universitat Ramon Llull, Barcelona, Spain., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Skøyen, 0213, PO 222, Oslo, Norway., Njølstad PR; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.; Children and Youth Clinic, Haukeland University Hospital, Bergen, Norway., Andreassen OA; Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Corfield EC; Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway.; Nic Waals Institute, Lovisenberg Diakonale Hospital, Oslo, Norway., Havdahl A; Center for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway.; Nic Waals Institute, Lovisenberg Diakonale Hospital, Oslo, Norway.; ROMENTA Research Center, Department of Psychology, P, University of Oslo, Oslo, Norway.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Næss Ø; Institute of Health and Society, University of Oslo, Oslo, Norway.; Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway., Brumpton B; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.; HUNT Research Centre, Department of Public Health and Nursing, Norwegian University of Science and Technology, Levanger, Norway.; Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Åsvold BO; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.; HUNT Research Centre, Department of Public Health and Nursing, Norwegian University of Science and Technology, Levanger, Norway.; Department of Endocrinology, Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Lawlor DA; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK., Fraser A; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK., Magnus MC; Centre for Fertility and Health, Norwegian Institute of Public Health, Skøyen, 0213, PO 222, Oslo, Norway.

Publikováno v: BMC medicine [BMC Med] 2024 Jan 25; Vol. 22 (1), pp. 35. Date of Electronic Publication: 2024 Jan 25.

Risk of cardiovascular disease in women and men with subfertility: the Trøndelag Health Study.

Autor: Skåra KH; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: karolinehansen.skara@fhi.no., Åsvold BO; K.G. Jebsen Centre for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway; HUNT Research Centre, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Levanger, Norway; Department of Endocrinology, Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Hernáez Á; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway; Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain; Blanquerna School of Health Sciences, Universitat Ramon Llull, Barcelona, Spain., Fraser A; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom; National Institute for Health Research Bristol Biomedical Research Centre, Bristol, United Kingdom., Rich-Edwards JW; Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts., Farland LV; Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona; Department of Obstetrics and Gynecology, College of Medcine-Tucson, University of Arizona, Tucson, Arizona., Næss Ø; Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway; Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway., Lawlor DA; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom; National Institute for Health Research Bristol Biomedical Research Centre, Bristol, United Kingdom., Brumpton B; K.G. Jebsen Centre for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway; HUNT Research Centre, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Levanger, Norway; Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Magnus MC; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Publikováno v: Fertility and sterility [Fertil Steril] 2022 Sep; Vol. 118 (3), pp. 537-547. Date of Electronic Publication: 2022 Jul 13.